Friday, October 30, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity

Rambam Maimonides medical journal · 2026 Oct 26 · Jani HT, Levine H, Patel A et

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 25 20:00 ETSource: Rambam Maimonides medical journal

From the source

Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity

Rambam Maimonides medical journal · 2026 Oct 26 · Jani HT, Levine H, Patel A et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →